Opiant Pharmaceuticals, Inc. (OPNT) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Opiant Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
49.46
Weak
WeakModerateStrong
P/B Ratio
3.20
Strong
WeakModerateStrong
Earnings Yield
2.01%
Yield Trap
WeakModerateStrong
Profitability Health
2021Return on Equity
6.42%
Weak
WeakModerateStrong
Operating Margin
12.66%
Moderate
WeakModerateStrong
Net Profit Margin
7.39%
Weak
WeakModerateStrong
Growth Indicators
2021Revenue Growth
48.62%
Strong
WeakModerateStrong
Net Income Growth
261.69%
Strong
WeakModerateStrong
EPS Growth
254.55%
Strong
WeakModerateStrong
Efficiency & Liquidity
2021Current Ratio
10.10
Strong
WeakModerateStrong
Quick Ratio
442.49
Strong
WeakModerateStrong
Asset Turnover
0.58x
Moderate
WeakModerateStrong
Inventory Turnover
-0.00x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
1.29%
Weak
WeakModerateStrong
EV / Free Cash Flow
67.00x
Weak
WeakModerateStrong
Net Debt / EBITDA
-3.56x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.588
Weak
WeakModerateStrong
Return on Invested Capital
8.00%
Weak
WeakModerateStrong
Cash Conversion Cycle
-119184.34 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for OPNT.
View Financial Statements